Kelly Mitchell is an Ophthalmology physician affiliated with Texas Tech University. OpenAlex indexes 35 publications with 468 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 4th St
2a100
Lubbock, TX 794300002
Telephone
806-743-2020Registry record last updated 6 Jan 2014.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dutch Ophthalmic, USAProgram year20251 payment
- Genentech USA, Inc.Program year20251 payment
- Nova Eye, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
98.4%Antineovascularisation agents97.2%Faricimab-svoa100%Part B, office-administered≥63 patientsProstaglandin Analog0.4%Latanoprost100%Part D≥14 patients+ 3 more classes in this area
Cancer & immunology
1%Vascular Endothelial Growth Factor Inhibitor1%Aflibercept75%Bevacizumab25%Part B, office-administered≥21 patientsCardiovascular
0.4%Beta blocker0.4%Timolol Maleate100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ophthalmology Encounters During the COVID-19 Pandemic in a Student Run Free Clinic
Journal of Student-Run Clinics
2024 - The Activity of Substance P (SP) on the Corneal Epithelium
Journal of Clinical & Translational Ophthalmology
2023 - Minocycline and Diacetyl Minocycline Eye Drops Reduce Ocular Neovascularization in Mice
Translational Vision Science & Technology
2023 - Immediate sequential bilateral vitreoretinal surgery (ISBVS): retrospective study from a tertiary academic center
Graefe s Archive for Clinical and Experimental Ophthalmology
2023 - The in vitro efficacy of betadine antiseptic solution and colloidal silver gel combination in inhibiting the growth of bacterial biofilms
American Journal of Infection Control
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Ariwan Rakvit, MD
Texas Tech University
Biff Palmer, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”